RFA
NVRO

Reilly Financial Advisors’s NEVRO CORP. NVRO Stock Holding History

Reilly Financial Advisors’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-60
Closed -$4K – 1068
2017
Q4 		$4K Hold
60
– – ﹤0.01% 823
2017
Q3 		$5K Hold
60
– – ﹤0.01% 774
2017
Q2 		$4K Hold
60
– – ﹤0.01% 822
2017
Q1 		$6K Buy
+60
New +$5.43K ﹤0.01% 713

Other funds holding NVRO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Reilly Financial Advisors's NVRO Position: Q1 2018 in Review

Reilly Financial Advisors sold out of NEVRO CORP. (NVRO) in Q1 2018, closing a stake of 60 shares — an estimated $4K sold.

Reilly Financial Advisors first reported a position in NVRO in Q1 2017 and held it in 4 quarters. The position peaked at $6K in Q1 2017. 197 funds tracked by Wall St. Rank hold NVRO as of Q1 2018.

  • Reilly Financial Advisors reported no remaining NEVRO CORP. position as of Q1 2018 after selling out during the quarter.
  • Reilly Financial Advisors sold 60 NEVRO CORP. shares in Q1 2018, an estimated $4K.
  • Reilly Financial Advisors first reported a position in NEVRO CORP. in Q1 2017 and held it in 4 quarters.
  • Reilly Financial Advisors's NEVRO CORP. position peaked at $6K in Q1 2017.
  • 197 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2018.

Based on Reilly Financial Advisors's 13F filing for Q1 2018, filed 30 Apr 2018.